IP Library › Granted Patent US 10,982,202
Granted Patent B2
US 10,982,202 · App. 15/983,725 · Granted Apr 20, 2021

Recombinant factor C and method for producing the same, and method for measuring endotoxin

Inventors: Hikaru Mizumura (Tokyo, JP); Toshio Oda (Tokyo, JP); Shun-ichiro Kawabata (Fukuoka, JP)
Assignee: SEIKAGAKU CORPORATION
C12N9/6408C12Y304/21069C12Y304/21084G01N33/56911G01N33/579G01N2333/96411
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,982,202
App. No.
15/983,725
Granted
Apr 20, 2021
Kind
B2
Abstract

To provide a method for producing a horseshoe crab recombinant Factor C. The horseshoe crab recombinant Factor C is produced through expression thereof by use of mammalian cells such as CHO DG44 and HEK293 as host cells.

Claims (32)

1. A method for imparting a salt ion resistance for a horseshoe crab Factor C, the method comprising:

recombinantly expressing and secreting the horseshoe crab Factor C into a culture broth or a culture supernatant using a mammalian cell as a host cell, and

recovering the recombinant horseshoe crab Factor C secreted from the mammalian cell,

wherein the horseshoe crab Factor C recombinantly expressed and secreted using the mammalian cell contains (α-2,3)-linked terminal sialic acid in a greater amount, as compared with a corresponding horseshoe crab Factor C expressed using a Sf9 insect cell as a host cell,

wherein the mammalian cell is a Chinese hamster ovary (CHO) cell or a human embryonic kidney (HEK) cell, and

wherein the horseshoe crab Factor C recombinantly expressed and secreted into a culture broth or a culture supernatant using the mammalian cell is a protein selected from the following (A), (B), (C), or (D):

(A) a protein comprising the amino acid sequence of Factor C of Tachypleus tridentatus , wherein the protein has no peptide added to the N-terminus of Factor C of Tachypleus tridentatus , and wherein the protein has activity of Factor C;

(B) a protein comprising the amino acid sequence of Factor C of Limulus polyphemus , wherein the protein has no peptide added to the N-terminus of Factor C of Limulus polyphemus , and wherein the protein has activity of Factor C;

(C) a protein comprising the amino acid sequence of Factor C of Carcinoscorpius rotundicauda , wherein the protein has no peptide added to the N-terminus of Factor C of Carcinoscorpius rotundicauda , and wherein the protein has activity of Factor C;

(D) a protein comprising the amino acid sequence of Factor C of Tachypleus gigas , wherein the protein has no peptide added to the N-terminus of Factor C of Tachypleus gigas , and wherein the protein has activity of Factor C.

2. The method according to claim 1 , wherein the salt ion is selected from the group consisting of sodium ion, potassium ion, calcium ion, and magnesium ion.

3. The method according to claim 1 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 21 mM sodium citrate as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

4. The method according to claim 1 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 52 mM sodium hydrogencarbonate as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

5. The method according to claim 1 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 214 mM sodium chloride as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

6. The method according to claim 1 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 16 mM magnesium sulfate as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

7. The method according to claim 1 , wherein the protein comprises the amino acid sequence of Factor C of Tachypleus tridentatus, Limuluspolyphemus , or Carcinoscorpius rotundicauda.

8. A method for producing an endotoxin assay agent comprising a horseshoe crab Factor C, the method comprising:

recombinantly expressing and secreting the horseshoe crab Factor C into a culture broth or a culture supernatant using a mammalian cell as a host cell,

recovering the recombinant horseshoe crab Factor C secreted from the mammalian cell, and

producing an endotoxin assay agent comprising the recombinant horseshoe crab Factor C,

wherein the horseshoe crab Factor C recombinantly expressed and secreted using the mammalian cell contains (α-2,3)-linked terminal sialic acid in a greater amount, as compared with a corresponding horseshoe crab Factor C expressed using a Sf9 insect cell as a host cell,

wherein the mammalian cell is a Chinese hamster ovary (CHO) cell or a human embryonic kidney (HEK) cell, and

wherein the horseshoe crab Factor C recombinantly expressed and secreted into a culture broth or a culture supernatant using the mammalian cell is a protein selected from the following (A), (B), (C), or (D):

(A) a protein comprising the amino acid sequence of Factor C of Tachypleus tridentatus , wherein the protein has no peptide added to the N-terminus of Factor C of Tachypleus tridentatus , and wherein the protein has activity of Factor C;

(B) a protein comprising the amino acid sequence of Factor C of Limulus polyphemus , wherein the protein has no peptide added to the N-terminus of Factor C of Limulus polyphemus , and wherein the protein has activity of Factor C;

(C) a protein comprising the amino acid sequence of Factor C of Carcinoscorpius rotundicauda , wherein the protein has no peptide added to the N-terminus of Factor C of Carcinoscorpius rotundicauda , and wherein the protein has activity of Factor C;

(D) a protein comprising the amino acid sequence of Factor C of Tachypleus gigas , wherein the protein has no peptide added to the N-terminus of Factor C of Tachypleus gigas , and wherein the protein has activity of Factor C.

9. The method according to claim 8 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 21 mM sodium citrate as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

10. The method according to claim 8 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 52 mM sodium hydrogencarbonate as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

11. The method according to claim 8 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 214 mM sodium chloride as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

12. The method according to claim 8 , wherein the horseshoe crab Factor C recombinantly expressed and secreted using a mammalian cell exhibits a higher residual activity in the presence of 16 mM magnesium sulfate as compared with a corresponding horseshoe crab Factor C expressed in a Sf9 insect cell as a host cell.

13. The method according to claim 8 , wherein the protein comprises the amino acid sequence of Factor C of Tachypleus tridentatus, Limuluspolyphemus , or Carcinoscorpius rotundicauda.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2025
From: MIZUMURA, HIKARU; ODA, TOSHIO; KAWABATA, SHUN-ICHIRO
To: SEIKAGAKU CORPORATION
Reel/Frame 071644/0258 →
Priority Claims (1)
JP 2012-269840 · Dec 10, 2012 · national
Continuity (2)
Continuation 14650767
Related Publication 20180258414A1 · Sep 13, 2018